Becker's muscular dystrophy

4 trials 1 recruiting MedDRA PT
4 Registered trials
1 Recruiting
2 Unique sponsors
1 Unique IMPs
4 Commercial trials
Drug classes (ATC)
— ATC code not specified 5
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 3 Phase I (Other): 2

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase II

3 trials
  • Edgewise Therapeutics Inc. Commercial
    EDG-5506
    2022-500090-13-00 7 countries 2022 n=81
    Ended
  • Edgewise Therapeutics Inc. Commercial
    EDG-5506
    2022-500215-39-00 1 country 2022 n=21
    Ended
  • Edgewise Therapeutics Inc. Commercial
    EDG-5506
    2023-506231-15-00 7 countries 2024 n=82
    Recruiting

Phase I (Other)

2 trials
  • Santhera Pharmaceuticals (Schweiz) AG Commercial
    IMP not specified
    2024-512101-60-00 1 country 2024 n=30
    Ended
  • Santhera Pharmaceuticals (Schweiz) AG Academic
    IMP not specified
    2024-512101-60-00 1 country 2024 n=30
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Edgewise Therapeutics Inc. Commercial 3 Phase II 1
Santhera Pharmaceuticals (Schweiz) AG Commercial 2 Phase I (Other) 0
New trials by year
2022
2
2024
3
← All indication landscapes